Phase II Study of NGR-hTNF in Combination With Doxorubicin in Patients Affected by Soft Tissue Sarcomas.

Clinical trial NCT00484341 · COMPLETED

Trial details

NCT number: NCT00484341
Sponsor: AGC Biologics S.p.A.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Adult Soft Tissue Sarcoma

Start date: 2010-10-01
Primary completion: 2016-05-01
Enrollment: 69

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.